Issue |
BIO Web Conf.
Volume 182, 2025
The 3rd International Conference on Food Science and Bio-medicine (ICFSB 2025)
|
|
---|---|---|
Article Number | 02008 | |
Number of page(s) | 9 | |
Section | Biomedical Research and Applications | |
DOI | https://doi.org/10.1051/bioconf/202518202008 | |
Published online | 02 July 2025 |
Antibacterial activity of 5-bromo substituted phenyl N-acylhydrazone derivatives with aromatic substitution at ortho- and para- directors as potential adjuvants
1 Faculty of Science, Department of Agricultural and Food Science, Universiti Tunku Abdul Rahman, Kampar, Perak, 31900, Malaysia
2 Faculty of Science, Department of Chemical Science, Universiti Tunku Abdul Rahman, Kampar, Perak, 31900, Malaysia
* Corresponding author: teokc@utar.edu.my
Antibiotics are frequently used in the food industry to ensure food safety and sustainability, predominantly in treating bacterial infections in food animals. Due to the massive use of antibiotics, emergence of antibiotic resistance (ABR) and multidrug resistance (MDR) threaten public health. Antibiotic adjuvants serve as an alternative strategy to combat these issues. N-acylhydrazone (NAH) has been proven to be a promising and versatile motif in drug design and medicinal chemistry due to its pronounced antimicrobial effect. Nine chemically synthesised NAH derivatives were tested for in vitro antibacterial activity against selected Gram-positive, Gram-negative and resistant strains using broth microdilution assay to determine minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). The study showed that Compound 9 exhibited the highest antibacterial activity against Bacillus subtilis and Pseudomonas aeruginosa (MIC and MBC = 62.50 µg/mL) among the nine tested compounds. Furthermore, the interaction between tested compounds and streptomycin were evaluated through calculation of fractional inhibitory concentration (FIC) index. Combination of all tested compounds with streptomycin demonstrated strong to moderate inhibitory activity against all tested bacterial strains (MIC = 7.81–62.50 µg/mL), while Compounds 1 and 2 were potential adjuvants due to synergistic effect observed in combination with streptomycin against Staphylococcus aureus.
© The Authors, published by EDP Sciences, 2025
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.